Aclaris Therapeutics (ACRS)
(Real Time Quote from BATS)
$1.28 USD
+0.01 (0.79%)
Updated Jul 11, 2024 10:20 AM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | 14.29% |
ABR | 2.78 |
Earnings ESP
|
8.11% |
---|---|
Current Year | -0.78 |
Next Year | -0.69 |
EPS (TTM) | -1.37 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.74M | 1.79M | 7.74M | 7.55M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 2.50M | 2.60M | 10.19M | 12.19M |
Low Estimate | 0.66M | 0.66M | 4.37M | 2.63M |
Year ago Sales | 1.87M | 9.28M | 31.25M | 7.74M |
Year over Year Growth Est. | -6.79% | -80.68% | -75.22% | -2.45% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.18 | -0.78 | -0.69 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.17 | -0.17 | -0.75 | -0.75 |
High Estimate | -0.12 | -0.10 | -0.53 | -0.40 |
Low Estimate | -0.24 | -0.29 | -1.08 | -1.35 |
Year ago EPS | -0.42 | -0.41 | -1.55 | -0.78 |
Year over Year Growth Est. | 54.76% | 56.10% | 49.68% | 11.36% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.18 | -0.78 | -0.69 |
7 Days Ago | -0.19 | -0.18 | -0.78 | -0.69 |
30 Days Ago | -0.20 | -0.19 | -0.81 | -0.73 |
60 Days Ago | -0.20 | -0.19 | -0.81 | -0.73 |
90 Days Ago | -0.23 | -0.21 | -0.98 | -0.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.17 | -0.75 | -0.75 |
Zacks Consensus Estimate | -0.19 | -0.18 | -0.78 | -0.69 |
Earnings ESP | 8.11% | 6.42% | 3.67% | -8.70% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | -0.30 | -0.41 | -0.42 | NA |
Estimate | -0.28 | -0.37 | -0.48 | -0.45 | NA |
Difference | 0.04 | 0.07 | 0.07 | 0.03 | 0.05 |
Surprise | 14.29% | 18.92% | 14.58% | 6.67% | 13.62% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more